{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T16:52:20Z","timestamp":1767977540289,"version":"3.49.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,4,12]],"date-time":"2020-04-12T00:00:00Z","timestamp":1586649600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,12]],"date-time":"2020-04-12T00:00:00Z","timestamp":1586649600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81300070"],"award-info":[{"award-number":["81300070"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770399"],"award-info":[{"award-number":["81770399"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81530012"],"award-info":[{"award-number":["81530012"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81700218"],"award-info":[{"award-number":["81700218"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2042018kf0121"],"award-info":[{"award-number":["2042018kf0121"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2042018kf1032"],"award-info":[{"award-number":["2042018kf1032"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2018YFC1311300"],"award-info":[{"award-number":["2018YFC1311300"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004572","name":"National Health and Family Planning Commission of the People's Republic of China","doi-asserted-by":"publisher","award":["2016ZX-008-01"],"award-info":[{"award-number":["2016ZX-008-01"]}],"id":[{"id":"10.13039\/501100004572","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2017CFB320"],"award-info":[{"award-number":["2017CFB320"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s00109-020-01896-w","type":"journal-article","created":{"date-parts":[[2020,4,12]],"date-time":"2020-04-12T11:02:05Z","timestamp":1586689325000},"page":"691-705","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Leukocyte immunoglobulin-like receptor B4 protects against cardiac hypertrophy via SHP-2-dependent inhibition of the NF-\u03baB pathway"],"prefix":"10.1007","volume":"98","author":[{"given":"Heng","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Ge","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingqing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhou-Yan","family":"Bian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di-Fei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongliang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi-Zhu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,12]]},"reference":[{"issue":"5","key":"1896_CR1","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00395-018-0698-6","volume":"113","author":"H Zhou","year":"2018","unstructured":"Zhou H, Li N, Yuan Y, Jin YG, Guo H, Deng W, Tang QZ (2018) Activating transcription factor 3 in cardiovascular diseases: a potential therapeutic target. Basic Res Cardiol 113(5):37","journal-title":"Basic Res Cardiol"},{"issue":"5","key":"1896_CR2","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.jelectrocard.2014.06.002","volume":"47","author":"PM Rautaharju","year":"2014","unstructured":"Rautaharju PM, Soliman EZ (2014) Electrocardiographic left ventricular hypertrophy and the risk of adverse cardiovascular events: a critical appraisal. J Electrocardiol 47(5):649\u2013654","journal-title":"J Electrocardiol"},{"issue":"18","key":"1896_CR3","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1042\/CS20171167","volume":"131","author":"QQ Wu","year":"2017","unstructured":"Wu QQ, Xiao Y, Yuan Y, Ma ZG, Liao HH, Liu C, Zhu JX, Yang Z, Deng W, Tang QZ (2017) Mechanisms contributing to cardiac remodelling. Clin Sci (Lond) 131(18):2319\u20132345","journal-title":"Clin Sci (Lond)"},{"issue":"10","key":"1896_CR4","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1084\/jem.185.10.1743","volume":"185","author":"M Cella","year":"1997","unstructured":"Cella M, Dohring C, Samaridis J, Dessing M, Brockhaus M, Lanzavecchia A, Colonna M (1997) A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processing. J Exp Med 185(10):1743\u20131751","journal-title":"J Exp Med"},{"issue":"4","key":"1896_CR5","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1002\/eji.200324593","volume":"35","author":"YT Bryceson","year":"2005","unstructured":"Bryceson YT, Torgersen KM, Inngjerdingen M, Berg SF, Hoelsbrekken SE, Fossum S, Dissen E (2005) The rat orthologue to the inhibitory receptor gp49B is expressed by neutrophils and monocytes, but not by NK cells or mast cells. Eur J Immunol 35(4):1230\u20131239","journal-title":"Eur J Immunol"},{"issue":"9","key":"1896_CR6","doi-asserted-by":"publisher","first-page":"4970","DOI":"10.4049\/jimmunol.165.9.4970","volume":"165","author":"KH Lee","year":"2000","unstructured":"Lee KH, Ono M, Inui M, Yuasa T, Takai T (2000) Stimulatory function of gp49A, a murine Ig-like receptor, in rat basophilic leukemia cells. J Immunol 165(9):4970\u20134977","journal-title":"J Immunol"},{"key":"1896_CR7","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/j.1600-065X.2007.00522.x","volume":"217","author":"HR Katz","year":"2007","unstructured":"Katz HR (2007) Inhibition of pathologic inflammation by leukocyte Ig-like receptor B4 and related inhibitory receptors. Immunol Rev 217:222\u2013230","journal-title":"Immunol Rev"},{"issue":"2","key":"1896_CR8","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1074\/jbc.273.2.1070","volume":"273","author":"A Kuroiwa","year":"1998","unstructured":"Kuroiwa A, Yamashita Y, Inui M, Yuasa T, Ono M, Nagabukuro A, Matsuda Y, Takai T (1998) Association of tyrosine phosphatases SHP-1 and SHP-2, inositol 5-phosphatase SHIP with gp49B1, and chromosomal assignment of the gene. J Biol Chem 273(2):1070\u20131074","journal-title":"J Biol Chem"},{"issue":"50","key":"1896_CR9","doi-asserted-by":"publisher","first-page":"34839","DOI":"10.1074\/jbc.M109.035683","volume":"284","author":"HK Lu","year":"2009","unstructured":"Lu HK, Rentero C, Raftery MJ, Borges L, Bryant K, Tedla N (2009) Leukocyte Ig-like receptor B4 (LILRB4) is a potent inhibitor of FcgammaRI-mediated monocyte activation via dephosphorylation of multiple kinases. J Biol Chem 284(50):34839\u201334848","journal-title":"J Biol Chem"},{"issue":"1 Suppl","key":"1896_CR10","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1097\/01.tp.0000231437.12890.64","volume":"82","author":"R Cortesini","year":"2006","unstructured":"Cortesini R, Suciu-Foca N (2006) ILT3+ ILT4+ tolerogenic endothelial cells in transplantation. Transplantation 82(1 Suppl):S30\u2013S32","journal-title":"Transplantation"},{"issue":"1","key":"1896_CR11","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1177\/1352458509352794","volume":"16","author":"MA Jensen","year":"2010","unstructured":"Jensen MA, Yanowitch RN, Reder AT, White DM, Arnason BG (2010) Immunoglobulin-like transcript 3, an inhibitor of T cell activation, is reduced on blood monocytes during multiple sclerosis relapses and is induced by interferon beta-1b. Mult Scler 16(1):30\u201338","journal-title":"Mult Scler"},{"issue":"7728","key":"1896_CR12","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/s41586-018-0615-z","volume":"562","author":"M Deng","year":"2018","unstructured":"Deng M, Gui X, Kim J, Xie L, Chen W, Li Z, He L, Chen Y, Chen H, Luo W et al (2018) LILRB4 signalling in leukaemia cells mediates T cell suppression and tumour infiltration. Nature 562(7728):605\u2013609","journal-title":"Nature"},{"issue":"4","key":"1896_CR13","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1002\/hep.29633","volume":"67","author":"Y Lu","year":"2018","unstructured":"Lu Y, Jiang Z, Dai H, Miao R, Shu J, Gu H, Liu X, Huang Z, Yang G, Chen AF et al (2018) Hepatic leukocyte immunoglobulin-like receptor B4 (LILRB4) attenuates nonalcoholic fatty liver disease via SHP1-TRAF6 pathway. Hepatology 67(4):1303\u20131319","journal-title":"Hepatology"},{"key":"1896_CR14","doi-asserted-by":"publisher","unstructured":"Jiang Z, Qin JJ, Zhang Y, Cheng WL, Ji YX, Gong FH, Zhu XY, She ZG, Huang Z, Li H (2017) LILRB4 deficiency aggravates the development of atherosclerosis and plaque instability by increasing the macrophage inflammatory response via NF-kappaB signaling. Clin Sci (Lond) 131(17):2275\u20132288. https:\/\/doi.org\/10.1042\/CS20170198","DOI":"10.1042\/CS20170198"},{"key":"1896_CR15","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.1038\/ncomms4303","volume":"5","author":"DS Jiang","year":"2014","unstructured":"Jiang DS, Wei X, Zhang XF, Liu Y, Zhang Y, Chen K, Gao L, Zhou H, Zhu XH, Liu PP et al (2014) IRF8 suppresses pathological cardiac remodelling by inhibiting calcineurin signalling. Nat Commun 5:3303","journal-title":"Nat Commun"},{"issue":"4","key":"1896_CR16","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1161\/HYPERTENSIONAHA.113.02653","volume":"63","author":"DS Jiang","year":"2014","unstructured":"Jiang DS, Liu Y, Zhou H, Zhang Y, Zhang XD, Zhang XF, Chen K, Gao L, Peng J, Gong H et al (2014) Interferon regulatory factor 7 functions as a novel negative regulator of pathological cardiac hypertrophy. Hypertension 63(4):713\u2013722","journal-title":"Hypertension"},{"issue":"3","key":"1896_CR17","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1161\/HYPERTENSIONAHA.112.198895","volume":"60","author":"H Zhou","year":"2012","unstructured":"Zhou H, Bian ZY, Zong J, Deng W, Yan L, Shen DF, Guo H, Dai J, Yuan Y, Zhang R et al (2012) Stem cell antigen 1 protects against cardiac hypertrophy and fibrosis after pressure overload. Hypertension 60(3):802\u2013809","journal-title":"Hypertension"},{"issue":"8","key":"1896_CR18","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1161\/CIRCRESAHA.108.179754","volume":"103","author":"TM Marin","year":"2008","unstructured":"Marin TM, Clemente CF, Santos AM, Picardi PK, Pascoal VD, Lopes-Cendes I, Saad MJ, Franchini KG (2008) Shp2 negatively regulates growth in cardiomyocytes by controlling focal adhesion kinase\/Src and mTOR pathways. Circ Res 103(8):813\u2013824","journal-title":"Circ Res"},{"issue":"2","key":"1896_CR19","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3109\/08830180903281185","volume":"29","author":"G Vlad","year":"2010","unstructured":"Vlad G, Chang CC, Colovai AI, Vasilescu ER, Cortesini R, Suciu-Foca N (2010) Membrane and soluble ILT3 are critical to the generation of T suppressor cells and induction of immunological tolerance. Int Rev Immunol 29(2):119\u2013132","journal-title":"Int Rev Immunol"},{"issue":"10","key":"1896_CR20","doi-asserted-by":"publisher","first-page":"3490","DOI":"10.1182\/blood-2005-05-2044","volume":"106","author":"G Penna","year":"2005","unstructured":"Penna G, Roncari A, Amuchastegui S, Daniel KC, Berti E, Colonna M, Adorini L (2005) Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4+Foxp3+ regulatory T cells by 1,25-dihydroxyvitamin D3. Blood 106(10):3490\u20133497","journal-title":"Blood"},{"key":"1896_CR21","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/978-3-540-71029-5_9","volume":"188","author":"M Buckland","year":"2009","unstructured":"Buckland M, Lombardi G (2009) Aspirin and the induction of tolerance by dendritic cells. Handb Exp Pharmacol 188:197\u2013213","journal-title":"Handb Exp Pharmacol"},{"issue":"6","key":"1896_CR22","first-page":"449","volume":"2","author":"JS Tilstra","year":"2011","unstructured":"Tilstra JS, Clauson CL, Niedernhofer LJ, Robbins PD (2011) NF-kappaB in aging and disease. Aging Dis 2(6):449\u2013465","journal-title":"Aging Dis"},{"key":"1896_CR23","doi-asserted-by":"publisher","unstructured":"Christian F, Smith EL, Carmody RJ (2016) The regulation of NF-kappaB subunits by phosphorylation. Cells 5(1). https:\/\/doi.org\/10.3390\/cells5010012","DOI":"10.3390\/cells5010012"},{"issue":"12","key":"1896_CR24","doi-asserted-by":"publisher","first-page":"6668","DOI":"10.1073\/pnas.111155798","volume":"98","author":"NH Purcell","year":"2001","unstructured":"Purcell NH, Tang G, Yu C, Mercurio F, DiDonato JA, Lin A (2001) Activation of NF-kappa B is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes. Proc Natl Acad Sci U S A 98(12):6668\u20136673","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"1896_CR25","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1161\/CIRCRESAHA.111.260729","volume":"110","author":"Q Liu","year":"2012","unstructured":"Liu Q, Chen Y, Auger-Messier M, Molkentin JD (2012) Interaction between NFkappaB and NFAT coordinates cardiac hypertrophy and pathological remodeling. Circ Res 110(8):1077\u20131086","journal-title":"Circ Res"},{"issue":"3","key":"1896_CR26","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.jmb.2007.10.006","volume":"375","author":"S Gupta","year":"2008","unstructured":"Gupta S, Young D, Maitra RK, Gupta A, Popovic ZB, Yong SL, Mahajan A, Wang Q, Sen S (2008) Prevention of cardiac hypertrophy and heart failure by silencing of NF-kappaB. J Mol Biol 375(3):637\u2013649","journal-title":"J Mol Biol"},{"issue":"9","key":"1896_CR27","doi-asserted-by":"publisher","first-page":"5208","DOI":"10.4049\/jimmunol.0804048","volume":"182","author":"CC Chang","year":"2009","unstructured":"Chang CC, Liu Z, Vlad G, Qin H, Qiao X, Mancini DM, Marboe CC, Cortesini R, Suciu-Foca N (2009) Ig-like transcript 3 regulates expression of proinflammatory cytokines and migration of activated T cells. J Immunol 182(9):5208\u20135216","journal-title":"J Immunol"},{"key":"1896_CR28","doi-asserted-by":"publisher","unstructured":"Qiu T, Zhou J, Wang T, Chen Z, Ma X, Zhang L, Zou J (2019) Leukocyte immunoglobulin-like receptor B4 deficiency exacerbates acute lung injury via NF-kappaB signaling in bone marrow-derived macrophages. Biosci Rep 39(6). https:\/\/doi.org\/10.1042\/BSR20181888","DOI":"10.1042\/BSR20181888"},{"issue":"10","key":"1896_CR29","doi-asserted-by":"publisher","first-page":"e26744","DOI":"10.1371\/journal.pone.0026744","volume":"6","author":"H Zhou","year":"2011","unstructured":"Zhou H, Shen DF, Bian ZY, Zong J, Deng W, Zhang Y, Guo YY, Li H, Tang QZ (2011) Activating transcription factor 3 deficiency promotes cardiac hypertrophy, dysfunction, and fibrosis induced by pressure overload. PLoS One 6(10):e26744","journal-title":"PLoS One"},{"issue":"1","key":"1896_CR30","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.bbrc.2018.11.137","volume":"509","author":"Q Li","year":"2019","unstructured":"Li Q, Wei G, Tao T (2019) Leukocyte immunoglobulin-like receptor B4 (LILRB4) negatively mediates the pathological cardiac hypertrophy by suppressing fibrosis, inflammation and apoptosis via the activation of NF-kappaB signaling. Biochem Biophys Res Commun 509(1):16\u201323","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"1896_CR31","first-page":"1251","volume":"22","author":"ZZ Chong","year":"2007","unstructured":"Chong ZZ, Maiese K (2007) The Src homology 2 domain tyrosine phosphatases SHP-1 and SHP-2: diversified control of cell growth, inflammation, and injury. Histol Histopathol 22(11):1251\u20131267","journal-title":"Histol Histopathol"},{"issue":"10","key":"1896_CR32","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ejmg.2015.08.005","volume":"58","author":"M Tajan","year":"2015","unstructured":"Tajan M, de Rocca SA, Valet P, Edouard T, Yart A (2015) SHP2 sails from physiology to pathology. Eur J Med Genet 58(10):509\u2013525","journal-title":"Eur J Med Genet"},{"issue":"11","key":"1896_CR33","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1161\/CIRCULATIONAHA.107.728865","volume":"117","author":"MI Kontaridis","year":"2008","unstructured":"Kontaridis MI, Yang W, Bence KK, Cullen D, Wang B, Bodyak N, Ke Q, Hinek A, Kang PM, Liao R, Neel BG (2008) Deletion of Ptpn11 (Shp2) in cardiomyocytes causes dilated cardiomyopathy via effects on the extracellular signal-regulated kinase\/mitogen-activated protein kinase and RhoA signaling pathways. Circulation 117(11):1423\u20131435","journal-title":"Circulation"},{"issue":"11","key":"1896_CR34","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1128\/MCB.00043-13","volume":"33","author":"G Coulombe","year":"2013","unstructured":"Coulombe G, Leblanc C, Cagnol S, Maloum F, Lemieux E, Perreault N, Feng GS, Boudreau F, Rivard N (2013) Epithelial tyrosine phosphatase SHP-2 protects against intestinal inflammation in mice. Mol Cell Biol 33(11):2275\u20132284","journal-title":"Mol Cell Biol"},{"key":"1896_CR35","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ebiom.2019.03.034","volume":"42","author":"Y Heun","year":"2019","unstructured":"Heun Y, Pircher J, Czermak T, Bluem P, Hupel G, Bohmer M, Kraemer BF, Pogoda K, Pfeifer A, Woernle M et al (2019) Inactivation of the tyrosine phosphatase SHP-2 drives vascular dysfunction in sepsis. EBioMedicine 42:120\u2013132","journal-title":"EBioMedicine"},{"issue":"1","key":"1896_CR36","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1084\/jem.193.1.101","volume":"193","author":"M You","year":"2001","unstructured":"You M, Flick LM, Yu D, Feng GS (2001) Modulation of the nuclear factor kappa B pathway by Shp-2 tyrosine phosphatase in mediating the induction of interleukin (IL)-6 by IL-1 or tumor necrosis factor. J Exp Med 193(1):101\u2013110","journal-title":"J Exp Med"},{"issue":"2","key":"1896_CR37","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1128\/MCB.24.2.823-836.2004","volume":"24","author":"GS Kapoor","year":"2004","unstructured":"Kapoor GS, Zhan Y, Johnson GR, O'Rourke DM (2004) Distinct domains in the SHP-2 phosphatase differentially regulate epidermal growth factor receptor\/NF-kappaB activation through Gab1 in glioblastoma cells. Mol Cell Biol 24(2):823\u2013836","journal-title":"Mol Cell Biol"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-020-01896-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-020-01896-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-020-01896-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,11]],"date-time":"2021-04-11T23:03:01Z","timestamp":1618182181000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00109-020-01896-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,12]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["1896"],"URL":"https:\/\/doi.org\/10.1007\/s00109-020-01896-w","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,12]]},"assertion":[{"value":"28 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}